225 related articles for article (PubMed ID: 10453233)
21. [Combined treatment of external auditory canal diseases in dermatological practice].
Khamaganova IV; Piven' NP
Vestn Otorinolaringol; 2010; (2):66-8. PubMed ID: 20527091
[No Abstract] [Full Text] [Related]
22. Randomized trial of neomycin/dexamethasone spray vs drop preparation for the treatment of active chronic mucosal otitis media.
Connolly AA; Picozzi GL; Browning GG
Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):529-31. PubMed ID: 9466064
[TBL] [Abstract][Full Text] [Related]
23. [The species composition and sensitivity of pathogenic microflora responsible for the development of otitis externa diffusa to the components of Polidexa].
Krasnozhen VN; Pokrovskaya EM; Bayazitova LT
Vestn Otorinolaringol; 2018; 83(1):65-67. PubMed ID: 29488502
[TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis.
Shulman DG; Sargent JB; Stewart RH; Mester U
Eur J Ophthalmol; 1996; 6(4):361-7. PubMed ID: 8997575
[TBL] [Abstract][Full Text] [Related]
25. Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.
Dohar JE; Roland P; Wall GM; McLean C; Stroman DW
Curr Med Res Opin; 2009 Feb; 25(2):287-91. PubMed ID: 19192973
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy of two anti-bacterial/anti-inflammatory formulations (Auricularum otic powder and Dex-Otic drops) in the medical treatment of otitis externa.
Yaniv E; Shevro J; Nageris B; Lapidot M; Hadar T; Cahani B; Zegerman C
Curr Med Res Opin; 2002; 18(8):520-2. PubMed ID: 12564664
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic photographic comparison of drug delivery by ear-drops and by aerosol spray.
McGarry GW; Swan IR
Clin Otolaryngol Allied Sci; 1992 Aug; 17(4):359-60. PubMed ID: 1526058
[TBL] [Abstract][Full Text] [Related]
28. Use of prophylactic otic drops after tympanostomy tube insertion.
Ramadan HH; Tarazi T; Zaytoun GM
Arch Otolaryngol Head Neck Surg; 1991 May; 117(5):537. PubMed ID: 2021473
[TBL] [Abstract][Full Text] [Related]
29. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa.
Roland PS; Belcher BP; Bettis R; Makabale RL; Conroy PJ; Wall GM; Dupre S; Potts S; Hogg G; Weber K;
Am J Otolaryngol; 2008; 29(4):255-61. PubMed ID: 18598837
[TBL] [Abstract][Full Text] [Related]
30. [Clinically presumptive toxicity of various ear-drops].
Goffinet M
Acta Otorhinolaryngol Belg; 1977; 31(6):585-90. PubMed ID: 202140
[No Abstract] [Full Text] [Related]
31. Acute bacterial otitis externa: efficacy and safety of topical treatment with an antibiotic ear drop formulation in comparison to glycerol treatment.
Mösges R; Baues CM; Schröder T; Sahin K
Curr Med Res Opin; 2011 Apr; 27(4):871-8. PubMed ID: 21332272
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the treatment of otitis externa with 'Otosporin' and aluminium acetate: a report from a services practice in Cyprus.
Lambert IJ
J R Coll Gen Pract; 1981 May; 31(226):291-4. PubMed ID: 6273551
[TBL] [Abstract][Full Text] [Related]
33. Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspective.
Bonomo RA; Van Zile PS; Li Q; Shermock KM; McCormick WG; Kohut B
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):773-82. PubMed ID: 17914912
[TBL] [Abstract][Full Text] [Related]
34. Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*.
Drehobl M; Guerrero JL; Lacarte PR; Goldstein G; Mata FS; Luber S
Curr Med Res Opin; 2008 Dec; 24(12):3531-42. PubMed ID: 19032135
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of the synergistic activity of neomycin-polymyxin B association against pathogens responsible for otitis externa.
Tempera G; Mangiafico A; Genovese C; Giudice E; Mastrojeni S; Nicolosi D; Ferneri PM
Int J Immunopathol Pharmacol; 2009; 22(2):299-302. PubMed ID: 19505383
[TBL] [Abstract][Full Text] [Related]
36. Regression of conjunctival maltoma with topical antibiotics and steroids.
Far NY; Au WY; Chow C; Choi PC; Chan KH; Young AL
Ann Hematol; 2014 Feb; 93(2):331-2. PubMed ID: 23657798
[No Abstract] [Full Text] [Related]
37. Tympanostomy tubes and otic suspensions: do they reach the middle ear space?
Hebert RL; Vick ML; King GE; Bent JP
Otolaryngol Head Neck Surg; 2000 Mar; 122(3):330-3. PubMed ID: 10699804
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of some inflammatory disorders of the ear with an association of fluocinolone acetonide, polymyxin B and neomycin].
Pannone T
Boll Mal Orecch Gola Naso; 1970; 88(1):65-77. PubMed ID: 4324718
[No Abstract] [Full Text] [Related]
39. Ammonia abolishers: antibiotics for hepatic encephalopathy.
Felicilda-Reynaldo RF
Medsurg Nurs; 2012; 21(3):173-5; quiz 176. PubMed ID: 22866441
[No Abstract] [Full Text] [Related]
40. A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media.
Tong MC; Woo JK; van Hasselt CA
J Laryngol Otol; 1996 Apr; 110(4):309-14. PubMed ID: 8733449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
